Optimizing patient access to medications: the American Dermatological Association’s position statement on pharmacy benefit managers and patient access to affordable and appropriate medications

American Dermatological Association

25 May 2020 - Access to health care has been at the forefront of social and political debate for decades. 

Reliable and equitable access to provider prescribed medications is tantamount to the delivery of appropriate health care, and the lifecycle of medication manufacturing, distribution, pricing and procurement has been shrouded in an incomprehensible array of transactions and involved stakeholders. 

Among the middlemen interspersed between pharmaceutical manufacturers and patients are pharmacy benefit managers.

Read American Dermatological Association statement

Michael Wonder

Posted by:

Michael Wonder